High-dose-rate intraoperative irradiation: Current status and future directions

Seminars in Radiation Oncology

Volumn 12, Issue 1, 2002, Pages 62-80

  Hu, Kenneth S ^a,b   Enker, Warren E ^a,b   Harrison, Louis B ^a,b  

^a BETH ISRAEL MEDICAL CENTER   (United States)

^b ST LUKE S ROOSEVELT HOSPITAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BEAM THERAPY; CANCER; CANCER RADIOTHERAPY; CLINICAL TRIAL; COLORECTAL CANCER; ELECTRON; FEMALE GENITAL TRACT CANCER; GAMMA IRRADIATION; HEAD AND NECK CANCER; HUMAN; INTRAOPERATIVE PERIOD; IRRADIATION; MULTICENTER STUDY; PELVIS TUMOR; PHOTON; PRIORITY JOURNAL; RADIATION DOSE; RECTUM CANCER; RETROPERITONEAL SARCOMA; REVIEW; TREATMENT OUTCOME;

EID: 0036145974     PISSN: 10534296     EISSN: None     Source Type: Journal    
DOI: 10.1053/srao.2002.28666     Document Type: Article

References (85)

1. Intraoperative radiotherapy: The Japanese experience
2. Intraoperative irradiation with electronbeam or high-dose-rate brachytherapy
3. High-dose-rate intraoperative irradiation (HDR-IORT)
4. Intraoperative electron and external beam irradiation with or without 5-fluorouracil and maximum surgical resection for previously unirradiated, locally recurrent colorectal cancer
5. Intraoperative electron beam radiotherapy in the treatment of unresectable rectal cancer
6. Treatment of locally advanced rectal cancer with external beam radiation, surgical resection, and intraoperative radiation therapy
7. Indications for and results of combined modality treatment of colorectal cancer
8. Preoperative irradiation for unresectable rectal and rectosigmoid carcinomas
9. Preoperative irradiation for tethered rectal carcinoma
10. Abdominal sacral resection of locally recurrent rectal cancer
11. Pelvic recurrence of rectal cancer. Options for curative resection
12. Tolerance of retroperitoneal structures to intraoperative radiation
13. Experimental and clinical studies with intraoperative radiotherapy
14. Tolerance of peripheral nerve to intraoperative radiotherapy (IORT): Clinical and experimental studies
15. Peripheral neuropathies following experimental intraoperative radiation therapy (IORT)
16. Threshold dose for peripheral neuropathy following intraoperative radiotherapy (IORT) in a large animal model
17. High dose rate intraoperative radiation therapy (HDR-IORT) as part of the management strategy for locally advanced primary and recurrent rectal cancer
18. High-dose-rate intraoperative brachytherapy for recurrent colorectal cancer
19. Locally advanced rectal cancer: Resection and intraoperative radiotherapy using the flab method combined with preoperative or postoperative radiochemotherapy
20. Three different intraoperative radiation modalities (electron beam, highdose-rate brachytherapy, and iodine-125 brachytherapy) in the adjuvant treatment of patients with recurrent colorectal adenocarcinoma
21. Locally advanced primary colorectal cancer: Intraoperative electron and external beam irradiation +/- 5-FU
22. Intraoperative irradiation after palliative surgery for locally recurrent rectal cancer
23. Long-term survival and patterns of failure after postoperative radiation therapy for subtotally resected rectal adenocarcinoma
24. Locally recurrent colorectal cancer: IOERT and EBRT +/-5-FU and maximal resection
25. Intraoperative electron beam radiation therapy for primary locally advanced rectal and rectosigmoid carcinoma
26. The impact of 5-fluorouracil and intraoperative electron beam radiation therapy on the outcome of patients with locally advanced primary and rectosignmoid carcinoma
27. Intraoperative radiation therapy for locally advanced recurrent rectal or rectosigmoid cancer
28. A phase I/II study of intraoperative radiotherapy in advanced unresectable or recurrent carcinoma of the rectum: A Radiation Therapy Oncology Group (RTOG) study
29. Intraoperative irradiation for locally recurrent colorectal cancer in previously irradiated patients
30. Peripheral nerve and ureteral tolerance to intraoperative radiation therapy: Clinical and doseresponse analysis
31. Intraoperative electron beam radiation therapy for locally recurrent rectal carcinoma
32. Intraoperative radiotherapy for recurrent and/or residual colorectal cancer
33. Preoperative infusional chemoradiation and surgery with or without an electron beam intraoperative boost for advanced primary rectal cancer
34. Complications of intraoperative radiation therapy
35. Are complications in intraoperative radiation therapy more frequent than in conventional treatment?
36. Locally advanced primary and recurrent gynecologic malignancies
37. Radical surgical resection and high dose intra-operative radiation therapy (HDR-IORT) in patients with recurrent gynecologic cancers
38. Intraoperative radiation therapy in gynecologic cancer: The Mayo Clinic experience
39. Intraoperative radiation therapy in gynecologic cancer: Update of the experience at a single institution
40. Intraoperative radiation therapy in recurrent carcinoma of the uterine cervix: Report of the French intraoperative group on 70 patients
41. Prognostic factors for local control in recurrent cervical carcinoma treated with IORT: Report of the French IORT Group
42. Intraoperative radiation therapy in pelvic recurrences of uterine cervix carcinomas
43. The use of intraoperative electron beam radiation therapy in the treatment of para-aortic metastases from gynecologic tumors: A pilot study
44. Diagnosis and management of retroperitoneal soft-tissue sarcoma
45. Conservative surgery and radiation therapy for soft tissue sarcomas
46. Prospective randomized evaluation of the role of limb-sparing surgery, radiation therapy, and adjuvant chemoimmunotherapy in the treatment of adult soft-tissue sarcomas
47. Treatment of the patient with stage MO soft tissue sarcoma
48. Long-term results of a prospective randomized trial of adjuvant brachytherapy in the management of completely resected soft tissue sarcomas of the extremity and superficial trunk
49. Management of primary and recurrent soft-tissue sarcoma of the retroperitoneum
50. Adjuvant radiation therapy of retroperitoneal sarcoma: The role of intraoperative radiotherapy (IORT)
51. Outcome and prognosis in retroperitoneal soft tissue sarcoma
52. Resectable retroperitoneal soft tissue sarcomas. The effect of extent of resection and postoperative radiation therapy on local tumor control
53. Improved survival following complete excision of retroperitoneal sarcomas
54. Retroperitoneal sarcoma: The University of Florida experience
55. Retroperitoneal soft-tissue sarcoma: Analysis of 500 patients treated and followed at a single institution
56. The continuing challenge of retroperitoneal sarcomas
57. Intraoperative radiotherapy in retroperitoneal sarcomas. Final results of a prospective, randomized, clinical trial
58. Results of multimodality therapy of resectable soft-tissue sarcomas of the retroperitoneum
59. High dose-rate intraoperative radiation therapy (HDR-IORT) for retroperitoneal sarcomas
60. High-dose-rate intraoperative radiation therapy (HDR-IORT) for retroperitoneal sarcomas
61. Preliminary results of phase I/II study of high-dose-rate intraoperative radiation therapy for pediatric tumors
62. High-dose rate intraoperative radiation therapy for pediatric solid tumors
63. High-dose-rate brachytherapy in childhood sarcomas: A local control strategy preserving bone growth and function
64. Intraoperative high-dose-rate brachytherapy after preoperative radiochemotherapy in the treatment of Ewing's sarcoma
65. Electron beam intraoperative radiation therapy for pediatric neoplasms
66. Clinical highlights from the National Cancer Data Base, 2000
67. Evaluation of the dose for postoperative radiation therapy of head and neck cancer: First report of a prospective randomized trial
68. Pilot study of intraoperative high dose rate brachytherapy for head and neck cancer
69. Mortality and morbidity with intraoperative radiotherapy for head and neck cancer
70. Intraoperative radiation therapy for advanced or recurrent head and neck cancer
71. Intraoperative radiotherapy of head and neck cancer
72. Intraoperative radiation therapy for recurrent head and neck cancer
73. Intraoperative radiation therapy (IORT) for head and neck cancer
74. Intra-operative radiotherapy - 5 Years of experience in the palliative treatment of recurrent and advanced head and neck cancers
75. Intraoperative electron beam radiotherapy for previously irradiated advanced head and neck malignancies
76. Adjuvant electron-beam IORT in high-risk head and neck cancer patients
77. IORT in the management of locally advanced or recurrent head and neck cancer
78. Intraoperative radiation therapy of hepatic metastases: Technical aspects and report of a pilot study
79. Intraoperative high-dose rate interstitial irradiation of hepatic metastases from colorectal carcinoma. Results of a phase I-II trial
80. Postoperative combined radiation and chemotherapy improves disease-free survival (DFS) and overall survival (OS) in resected adenocarcinoma of the stomach and g.e. junction. Results of intergroup study INT 0116 (SWOG 9008)
81. Survival advantage of combined chemoradiotherapy compared with resection as the initial treatment of patients with regional pancreatic carcinoma. An outcomes trial
82. Retroperitoneal soft tissue sarcomas: A pilot study of intraoperative radiation therapy
83. Intraoperative electron beam radiation therapy for primary locally advanced rectal or rectosigmoid carcinoma
84. Preliminary results of protocol RTOG 85-07: Phase II study of intraoperative radiation for retroperitoneal sarcomas